How is SRT Measured?
SRT is typically measured using a
list of spondaic words (two-syllable words with equal stress on both syllables) presented at gradually decreasing volumes. The patient is asked to repeat the words they hear, and the lowest volume at which they can correctly identify 50% of the words is noted as their SRT.
Importance of SRT in Cancer Patients
Cancer patients, especially those undergoing treatments like
chemotherapy or
radiation therapy, may experience hearing loss as a side effect. Monitoring SRT in these patients is crucial for early detection and management of hearing impairments. It helps in identifying the extent of hearing loss and guiding appropriate interventions.
What Are the Symptoms of Hearing Loss in Cancer Patients?
Cancer patients may experience various symptoms of hearing loss, including difficulty understanding speech, particularly in noisy environments, frequently asking others to repeat themselves, and perceiving sounds as muffled. Monitoring SRT can help in the early identification of these issues.
How Often Should SRT Be Monitored in Cancer Patients?
It is recommended that cancer patients undergoing ototoxic treatments have their hearing, including SRT, monitored before starting treatment, periodically during the treatment, and after the completion of therapy. This enables timely interventions and management strategies to prevent further auditory damage.
Interventions for Hearing Loss in Cancer Patients
When hearing loss is detected in cancer patients, several interventions can be considered. These include the use of
hearing aids,
cochlear implants, and assistive listening devices. Additionally, communication strategies, such as lip-reading and using visual aids, can be beneficial.
Role of Multidisciplinary Care
Addressing hearing loss in cancer patients requires a multidisciplinary approach. Audiologists, oncologists, and other healthcare providers need to work together to ensure comprehensive care. Regular communication and coordination among these professionals are vital for optimal patient outcomes.Research and Future Directions
Ongoing research is focused on understanding the mechanisms of ototoxicity and developing strategies to prevent and mitigate hearing loss in cancer patients. Investigations into less ototoxic chemotherapeutic agents and protective agents are promising areas of future research.
